1. Immunology and Inflammation
  2. Medicine

Vaginal immune activity increases after first-time intercourse

A study suggests the immune system in the vagina becomes more active after young women start having intercourse, which may increase or decrease sexually transmitted infection risk.
Press Pack
  • Views 357
  • Annotations

The immune system ramps up in the vagina after young women begin having intercourse, suggests an observational study published today in eLife.

The changes detected may have important implications for sexually transmitted infection (STI) risk. But the authors do not yet know if the changes increase or decrease the risk of acquiring an STI.

Girls and young women between the ages of 15 and 24 have a higher risk of acquiring an STI than older women. However, it has not been determined if riskier behavioural choices or physiological factors may explain the increased risk.

“We measured immune changes in young women before and after initiating sex to determine if immune changes may play a role in increased STI vulnerability,” says lead author Sean Hughes, a research scientist in the Department of Obstetrics and Gynecology at the University of Washington School of Medicine in Seattle, US.

Hughes and colleagues compared vaginal samples collected from 95 adolescent women in Kenya before or after they began having sexual intercourse. They found a sharp increase in proteins that control the immune response, including IL-1β, IL-2, and CXCL8, during the first year after the participants became sexually active. These changes were confirmed to not be due to pregnancy or having an STI.

The team reviewed data collected in two other studies to verify the result. One included 93 young women in Belgium, and another included 19 participants in the US. The combined data from those two studies also showed elevated levels of immune-controlling proteins, including IL-1β, IL-2, and CXCL8, after participants became sexually active.

“The initiation of sexual activity was associated with higher levels of immune mediators, but we don’t know for sure if the start of sexual activity caused the changes,” says co-senior Florian Hladik, professor in the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Center, Seattle, Washington. “Other factors associated with the timing of sex initiation, such as socioeconomic status, could have contributed to immune system changes.”

The consequences of this immune activation are also not clear. The immune changes detected in the study may help boost fertility or may be a protective defence against sexually transmitted infections. If it is an attempt at defence, it may inadvertently increase young women’s vulnerability to HIV infection by recruiting the CD4 T immune cells targeted by the virus to the vagina. More studies are needed to confirm the connection between the start of sexual activity and these immune changes and understand their consequences for young women’s sexual health.

“More research on the immune changes associated with the initiation of sexual activity may help us understand the elevated STI risk in young women,” says co-senior author Alison Roxby, Associate Professor of Infectious Disease and Global Health at the University of Washington School of Medicine. “It may also help us identify new ways to prevent STIs in this vulnerable population.”

Media contacts

  1. Emily Packer
    eLife
    e.packer@elifesciences.org
    +441223855373

  2. George Litchfield
    eLife
    g.litchfield@elifesciences.org

  3. Barbara Clements
    UW Medicine Media Relations
    bac60@uw.edu
    +2537405043

About

eLife transforms research communication to create a future where a diverse, global community of scientists and researchers produces open and trusted results for the benefit of all. Independent, not-for-profit and supported by funders, we improve the way science is practised and shared. From the research we publish, to the tools we build, to the people we work with, we’ve earned a reputation for quality, integrity and the flexibility to bring about real change. eLife receives financial support and strategic guidance from the Howard Hughes Medical Institute, Knut and Alice Wallenberg Foundation, the Max Planck Society and Wellcome. Learn more at https://elifesciences.org/about.

To read the latest Immunology & Inflammation research published in eLife, visit https://elifesciences.org/subjects/immunology-inflammation.

And for the latest in Medicine, see https://elifesciences.org/subjects/medicine.